BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Adler AI, Gunn E, Haworth CS, Bilton D. Characteristics of adults with and without cystic fibrosis-related diabetes. Diabet Med 2007;24:1143-8. [PMID: 17888134 DOI: 10.1111/j.1464-5491.2007.02252.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 van den Berg J, Kouwenberg J, Heijerman H. Demographics of glucose metabolism in cystic fibrosis. Journal of Cystic Fibrosis 2009;8:276-9. [DOI: 10.1016/j.jcf.2009.04.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
2 Bojunga J, Schlereth F. Diabetes mellitus Typ 3c – Prävalenz, Diagnose, Besonderheiten der Therapie. Diabetologe 2018;14:269-77. [DOI: 10.1007/s11428-018-0346-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
3 Blackman SM, Hsu S, Vanscoy LL, Collaco JM, Ritter SE, Naughton K, Cutting GR. Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis. J Clin Endocrinol Metab 2009;94:1302-9. [PMID: 19126627 DOI: 10.1210/jc.2008-2186] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
4 Cano Megías M, González Albarrán O. Diabetes en la fibrosis quística: una entidad diferente. Endocrinología y Nutrición 2015;62:38-44. [DOI: 10.1016/j.endonu.2014.06.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Fischman D, Nookala VK. Cystic Fibrosis-Related Diabetes Mellitus: Etiology, Evaluation, and Management. Endocrine Practice 2008;14:1169-79. [DOI: 10.4158/ep.14.9.1169] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Reverri EJ, Morrissey BM, Cross CE, Steinberg FM. Inflammation, oxidative stress, and cardiovascular disease risk factors in adults with cystic fibrosis. Free Radical Biology and Medicine 2014;76:261-77. [DOI: 10.1016/j.freeradbiomed.2014.08.005] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
7 Morton AM. Symposium 6: Young people, artificial nutrition and transitional care The nutritional challenges of the young adult with cystic fibrosis: transition: Conference on ‘Malnutrition matters’. Proc Nutr Soc 2009;68:430-40. [DOI: 10.1017/s0029665109990176] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
8 Megías MC, Albarrán OG, Vasco PG, Ferreiro AL, Carro LM. Influence of macrolides, nutritional support and respiratory therapies in diabetes and normal glucose tolerance in cystic fibrosis. A retrospective analysis of a cohort of adult and younger patients. Diabetes Metab Syndr 2015;9:1-6. [PMID: 25450813 DOI: 10.1016/j.dsx.2014.09.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
9 Rayas MS, Kelly A, Hughan KS, Daley T, Zangen D. Adrenal function in cystic fibrosis. J Cyst Fibros 2019;18 Suppl 2:S74-81. [PMID: 31679732 DOI: 10.1016/j.jcf.2019.08.023] [Reference Citation Analysis]
10 Hardin DS. Pharmacotherapy of diabetes in cystic fibrosis patients. Expert Opin Pharmacother 2010;11:771-8. [PMID: 20166842 DOI: 10.1517/14656561003592151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
11 Nisr RB, Moody AJ, Gilpin ML. Screening microorganisms for insulin binding reveals binding by Burkholderia multivorans and Burkholderia cenocepacia and novel attachment of insulin to Aeromonas salmonicida via the A-layer. FEMS Microbiol Lett 2012;328:93-9. [PMID: 22171975 DOI: 10.1111/j.1574-6968.2011.02484.x] [Reference Citation Analysis]
12 Adler AI, Shine B, Haworth C, Leelarathna L, Bilton D. Hyperglycemia and death in cystic fibrosis-related diabetes. Diabetes Care 2011;34:1577-8. [PMID: 21593303 DOI: 10.2337/dc10-2289] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
13 Tang H, Fu Y, Cui Y, He Y, Zeng X, Ploplis VA, Castellino FJ, Luo Y. Fibrinogen has chaperone-like activity. Biochem Biophys Res Commun 2009;378:662-7. [PMID: 19059206 DOI: 10.1016/j.bbrc.2008.11.112] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
14 Reihill JA, Moreland M, Jarvis GE, McDowell A, Einarsson GG, Elborn JS, Martin SL. Bacterial proteases and haemostasis dysregulation in the CF lung. J Cyst Fibros 2017;16:49-57. [PMID: 27839953 DOI: 10.1016/j.jcf.2016.10.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Jones GC, Chong ZM, Gilmour J, Matheson C, MacGregor G, Sainsbury CA. Patterns and Impact of Hypoglycemia, Hyperglycemia, and Glucose Variability on Inpatients with Insulin-Treated Cystic Fibrosis-Related Diabetes. Diabetes Ther 2016;7:575-82. [PMID: 27550550 DOI: 10.1007/s13300-016-0194-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
16 Adler AI, Shine BS, Chamnan P, Haworth CS, Bilton D. Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults. Diabetes Care. 2008;31:1789-1794. [PMID: 18535191 DOI: 10.2337/dc08-0466] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
17 Blackman SM, Hsu S, Ritter SE, Naughton KM, Wright FA, Drumm ML, Knowles MR, Cutting GR. A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis. Diabetologia 2009;52:1858-65. [PMID: 19585101 DOI: 10.1007/s00125-009-1436-2] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
18 Jones GC, Sainsbury CA. A Practical Approach to Glucose Abnormalities in Cystic Fibrosis. Diabetes Ther 2016;7:611-20. [PMID: 27752941 DOI: 10.1007/s13300-016-0205-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]